IN THE NEWS

Press Releases

20February2026

Ritedose Honored With SCbio’s 2026 Life Sciences Pinnacle Award for Organizational Contribution

South Carolina’s largest sterile CDMO recognized for visionary leadership, innovation, and community impact at SCbio’s annual Life + Science Conference.

Pinnacle Award for Organizational Contribution | Jody Chastain CEO of Ritedose accepting Pinnacle Award at SCbio Life Sciences Conference 2026

18November2025

A Season of Gratitude and Purpose: A Thanksgiving Message from Jody Chastain, CEO of Ritedose

Ritedose has been built on the generosity, mentorship, and support of countless individuals and organizations across South Carolina. And with that good fortune comes a responsibility to give back to our patients, our people, and our community.

29October2025

Ritedose Now Offers the Largest Nebulized Drug Portfolio in the U.S.: FDA Approves the Company to Manufacture Generic Tobramycin Inhalation Solution

The Ritedose Corporation (Ritedose) announced that the U.S. Food and Drug Administration (FDA) approved its manufacturing and distribution of Tobramycin Inhalation Solution to treat patients six years and older with infections of Pseudomonas aeruginosa, a common bacterial infection among cystic…

24September2025

Leading CDMO Enhances cGMP Lab Infrastructure to Strengthen Position

Ritedose is investing $17M to expand its cGMP labs, adding a 10,000 sq. ft. analytical chemistry facility and a 6,000 sq. ft. microbiology expansion to boost drug development and CDMO capabilities.

male scientist mixing chemicals in lab with text overlay "$17M expansion"

18June2025

Ritedose Unveils State-of-the-Art Distribution and Logistics Facility at Ritedose Performance Park

COLUMBIA, SC, June 18, 2025 – The Ritedose Corporation, a leading pharmaceutical manufacturer specializing in Blow-Fill-Seal (BFS) technology, today unveiled its new distribution and logistics facility at Performance Park during a ribbon-cutting ceremony. The grand opening event included Ritedose CEO…